Using advanced MRI to assess kidney health in donors, recipients, and healthy individuals
Official title: Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and Ageing
Run by Aalborg University Hospital · NCT06210555 · Data updated 2026-11-12
This study is testing if advanced MRI scans can help check kidney health in living kidney donors, transplant recipients, and healthy people without needing a biopsy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 96 (estimated) |
| Sponsor | Aalborg University Hospital Academic / other |
| Locations | 2 sites (Aarhus, Central Jutland and 1 other locations) |
| Status | Recruiting |
| Started | October 29, 2024 |
| Main results expected | March 1, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT06210555 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include living kidney donors, recipients of living donor kidneys, and healthy individuals with normal kidney function.
✕Probably not a fit
Patients with contraindications to MRI or severe claustrophobia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the use of multiparametric MRI (mpMRI) to evaluate renal fibrosis and function in living kidney donors, transplant recipients, and healthy controls. By employing various MRI techniques, the study seeks to provide a non-invasive alternative to renal biopsies, which are currently the gold standard for assessing kidney fibrosis. Participants will undergo MRI scans to measure different biophysical properties of kidney tissue, potentially leading to better monitoring of renal health and outcomes. The study will include a prospective cohort to gather comprehensive data on kidney function and fibrosis over time.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive method for monitoring kidney health, reducing the need for invasive biopsies.
How similar studies have gone: While there have been studies using mpMRI in other contexts, this specific application in living kidney donors and recipients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Living kidney donors and transplant recipients: Inclusion Criteria: * Approved as a living kidney donor or recipient of a kidney from a living donor. * Able to cooperate to an MRI examination Exclusion Criteria: * Contraindications to MRI due to incompatible foreign objects. * Severe claustrophobia Healthy controls: Inclusion Criteria: * Office BP \< 140/90 mmHg. (use of 1 antihypertensive drug allowed) * Normal eGFR. (CKD-EPI) * Urine albumin-to-creatinine ratio \< 30 mg/g. * Dipstick negative for hematuria and proteinuria. * Able to cooperate to an MRI examination. Exclusion Criteria: * Contraindications to MRI due to incompatible foreign objects. * Severe claustrophobia. * Pregnancy. * Condition(s) that would exclude living kidney donation.
Where it's running
-
Department of Renal Medicine, Aarhus University Hospital
Aarhus, Central Jutland, Denmark Recruiting -
Department of Nephrology, Aalborg University Hospital
Aalborg, North Denmark, Denmark Recruiting
Study contacts
- Principal investigator: Patrick Schjelderup, MD — Aalborg University Hospital
- Study coordinator: Patrick Schjelderup, MD
- Email: pasc@rn.dk
- Phone: +4522212589
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Italian Registry of Pediatric Dialysis: collecting data from kids on kidney replacement therapy
This registry in Italy tests how collecting epidemiological, clinical, and treatment data from children on dialysis or pre-emptive kidney transplants can help centers share protocols and improve care.
-
Intraoperative diuretics during deceased-donor kidney transplants
This trial tests whether using furosemide or mannitol during kidney transplant surgery affects delayed graft function in adults receiving a deceased-donor kidney.
-
Immune Reset to Enable Kidney Transplant for Highly Sensitized Patients
This study tests whether a temporary immune system reboot using a patient’s own stem cells can help highly sensitized kidney patients receive a compatible transplant.
-
Home-based exercise to boost fitness for people waiting for a kidney transplant
This study tests whether a 12-week, home-based exercise program plus a wearable activity tracker helps adults on the kidney transplant waiting list increase daily activity and improve physical function.
-
A six-week online self-management program for adults in Israel with chronic conditions
This six-week online group program will try to help adults in Israel who have chronic conditions—such as cancer survivors or kidney transplant recipients—learn practical skills to manage symptoms and daily health.
-
Vonoprazan to reduce delayed graft function after deceased-donor kidney transplant
This trial will test whether giving vonoprazan around the time of surgery lowers the chance of delayed graft function in adults receiving their first deceased-donor kidney transplant.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.